An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer

Genetics in Medicine

Volumn 5, Issue 5, 2003, Pages 353-363

  Ramsey, Scott D ^a,b   Burke, Wylie ^b   Clarke, Lauren ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bethesda guideline; Cost effectivenessness; Hereditary nonpolyposis colorectal cancer; Microsatellite instability; Screening

Indexed keywords

ARTICLE; COLON CANCER; COLON RESECTION; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FAMILIAL CANCER; FAMILY HISTORY; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HEALTH ECONOMICS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; OUTCOMES RESEARCH; PRACTICE GUIDELINE; SENSITIVITY ANALYSIS;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; HUMANS; MICROSATELLITE REPEATS;

EID: 0142031151     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000086626.03082.B5     Document Type: Article

References (55)

1. Lynch HT, Smyrk TC. Hereditary colorectal cancer. Semin Oncol 1999;26:478-484.
2. Ponz De Leon M. Descriptive epidemiology of hereditary non-polyposis colorectal cancer. Tumori 1996;82:102-106.
3. Aaltonen LA, Sankila R, Mecklin JP, Jarvinen H, Pukkala E, Peltomaki P et al. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev 1994;18:57-63.
4. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000;18:2193-2200.
5. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-1762.
6. Ponz De Leon M. Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 1994;26:209-214.
7. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-834.
8. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICC-HNPCC). Dis Colon Rectum 1991;34:424-425.
9. Nakahara M, Yokozaki H, Yasui W, Dohi K, Tahara E. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Cancer Epidemiol Biomarkers Prev 1997;6:1057-1064.
10. Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135:577-588.
11. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38:289-293.
12. Aitken J, Bain C, Ward M, Siskind V, MacLennan R. How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 1995;141:863-871.
13. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-248.
14. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-1487.
15. Marx J. Gene defect identified in common hereditary colon cancer. Science 1993;262:1645.
16. Danks DM. Colon cancer screening. Science 1994;264:13-14.
17. Benson AB III, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD et al. Update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000;18:3586-3588.
18. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, I: Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-919.
19. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1997). National Cancer Institute, DCCPS, Cancer Surveillance Research Program, Cancer Statistics Branch, 2000.
20. Houlston RS, Collins A, Slack J, Morton NE. Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992;56:99-103.
21. Gonzalez-Garcia I, Moreno V, Navarro M, Marti-Rague J, Marcuello E, Benasco C et al. Standardized approach for microsatellite instability detection in colorectal carcinomas. J Natl Cancer Inst 2000;92:544-549.
22. Syngal S, Fox EA, Li C, Dovidio M, Eng C, Kolodner RD et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 1999;282:247-253.
23. Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bulow S. Hereditary non-polyposis colorectal cancer: Clinical features and survival: Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-576.
24. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
25. Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D et al. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer 1997;71:373-376.
26. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-168.
27. Jentschura D, Raute M, Winter J, Henkel T, Kraus M, Manegold B.C. Complications in endoscopy of the lower gastrointestinal tract: Therapy and prognosis. Surg Endosc 1994;8:672-676.
28. Lo AY, Beaton HL. Selective management of colonoscopic perforations. J Am Coll Surg 1994;179:333-337.
29. Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: A report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983;24:376-383.
30. Rouffet F, Hay JM, Vacher B, Fingerhut A, Elhadad A, Flamant Y et al. Curative resection for left colonic carcinoma: Hemicolectomy vs. segmental colectomy: A prospective, controlled, multicenter trial. French Association for Surgical Research. Dis Colon Rectum 1994;37:651-659.
31. Stelzner M, Fonkalsrud EW. The endorectal ileal pullthrough procedure in patients with ulcerative colitis and familial polyposis with carcinoma. Surg Gynecol Obstet 1989;169:187-194.
32. Coran AG. A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults. Ann Surg 1990:212:242-247; discussion 247-248.
33. Pedersen T, Eliasen K, Henriksen E. A prospective study of mortality associated with anaesthesia and surgery: Risk indicators of mortality in hospital. Acta Anaesthesiol Scand 1990;34:176-182.
34. Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999;281:1618-1622.
35. Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 1993;22:284-292.
36. Kinney AY, Choi YA, DeVellis B, Kobetz E, Millikan RC, Sandler RS. Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med 2000;18:249-252.
37. Bernhardt BA, Peshkin BN, Kemel Y. Billing and record-keeping for familial cancer risk counseling: A national survey. J Genet Couns 1998;7:317-330.
38. Ramsey SD, Berry K, Etzioni R, Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol 2002;97:440-445.
39. Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: A colorectal cancer case study. Health Econ 2001;10:245-256.
40. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-748.
41. Moore AD. Owning genetic information and gene enhancement techniques: Why privacy and property rights may undermine social control of the human genome. Bioethics 2000;14:97-119.
42. Anderlik MR, Rothstein MA. Privacy and confidentiality of genetic information: What rules for the new science? Annu Rev Genomics Hum Genet 2001;2:401-433.
43. ASHG statement. Professional disclosure of familial genetic information: The American Society of Hum Genet Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 1998;62:474-483.
44. Brown ML, Kessler LG. The use of gene tests to detect hereditary predisposition to cancer: Economic considerations. J Natl Cancer Inst 1995;87:1131-1136.
45. Terdiman JP. HNPCC: An uncommon but important diagnosis. Gastroenterology 2001;121:1005-1008.
46. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-1048.
47. Bapat BV, Madlensky L, Temple LK, Hiruki T, Redston M, Baron DL et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet 1999;104:167-176.
48. Fornasarig M, Viel A, Bidoli E, Campagnutta E, Minisini AM, Cannizzaro R et al. Amsterdam criteria II, and endometrial cancer index cases for an accurate selection of HNPCC families. Tumori 2002;88:18-20.
49. Reyes CM, Allen BA, Terdiman JP, Wilson LS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: Effectiveness and cost-effectiveness. Cancer 2002;95:1848-1856.
50. Diagnostic Criteria for Hereditary Non-Polyposis Colorectal Cancer, and Microsatellite Instability. National Cancer Institute, Division of Cancer Prevention, 2002.
51. Burke W, and Emery, J, Genetics education for primary-care providers. Nat Rev Genet 2002;3:561-566.
52. Safer v. Estate of Pack. Atl Report 1996;677:1188-1193.
53. Pate v. Threlkel. Wests South Report 1995;661:278-282.
54. American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 2001;121:195-197.
55. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: The special case of end-stage renal disease treatment. Med Decis Making 2002;22:417-430.